Harrow Health Statistics Share Statistics Harrow Health has 37M
shares outstanding. The number of shares has increased by 3.43%
in one year.
Shares Outstanding 37M Shares Change (YoY) 3.43% Shares Change (QoQ) 3.05% Owned by Institutions (%) 57.87% Shares Floating 30.86M Failed to Deliver (FTD) Shares 1,590 FTD / Avg. Volume 0.32%
Short Selling Information The latest short interest is 4.82M, so 13.01% of the outstanding
shares have been sold short.
Short Interest 4.82M Short % of Shares Out 13.01% Short % of Float 16.41% Short Ratio (days to cover) 5.91
Valuation Ratios The PE ratio is -68.42 and the forward
PE ratio is 20.22.
Harrow Health's PEG ratio is
1.97.
PE Ratio -68.42 Forward PE 20.22 PS Ratio 5.99 Forward PS 3.5 PB Ratio 17.17 P/FCF Ratio -19.65 PEG Ratio 1.97
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Harrow Health.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.08,
with a Debt / Equity ratio of 3.29.
Current Ratio 2.08 Quick Ratio 1.96 Debt / Equity 3.29 Debt / EBITDA 11.87 Debt / FCF -3.76 Interest Coverage 0.39
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $522.55K Profits Per Employee $-45.76K Employee Count 382 Asset Turnover 0.51 Inventory Turnover 4.6
Taxes Income Tax 161K Effective Tax Rate -0.93%
Stock Price Statistics The stock price has increased by -2.61% in the
last 52 weeks. The beta is 0.33, so Harrow Health's
price volatility has been higher than the market average.
Beta 0.33 52-Week Price Change -2.61% 50-Day Moving Average 35.12 200-Day Moving Average 31.51 Relative Strength Index (RSI) 51.26 Average Volume (20 Days) 498,435
Income Statement In the last 12 months, Harrow Health had revenue of 199.61M
and earned -17.48M
in profits. Earnings per share was -0.49.
Revenue 199.61M Gross Profit 150.37M Operating Income 8.82M Net Income -17.48M EBITDA 19.28M EBIT 4.74M Earnings Per Share (EPS) -0.49
Full Income Statement Balance Sheet The company has 47.25M in cash and 228.83M in
debt, giving a net cash position of -181.58M.
Cash & Cash Equivalents 47.25M Total Debt 228.83M Net Cash -181.58M Retained Earnings -151,385B Total Assets 345.03M Working Capital -93.99M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -22.2M
and capital expenditures -38.67M, giving a free cash flow of -60.88M.
Operating Cash Flow -22.2M Capital Expenditures -38.67M Free Cash Flow -60.88M FCF Per Share -1.71
Full Cash Flow Statement Margins Gross margin is 75.33%, with operating and profit margins of 4.42% and -8.76%.
Gross Margin 75.33% Operating Margin 4.42% Pretax Margin -8.68% Profit Margin -8.76% EBITDA Margin 9.66% EBIT Margin 4.42% FCF Margin -30.5%
Dividends & Yields HROW does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for HROW is $64.5,
which is 74.4% higher than the current price. The consensus rating is "Strong Buy".
Price Target $64.5 Price Target Difference 74.4% Analyst Consensus Strong Buy Analyst Count 7
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Feb 8, 2013. It was a
backward
split with a ratio of 1:5.
Last Split Date Feb 8, 2013 Split Type backward Split Ratio 1:5
Scores Altman Z-Score 2.61 Piotroski F-Score 5
